Impact of the UK public smoking ban on the prescribing of smoking cessation therapy in primary care – a THIN database study

May-10

AUTHORS : Betina Blak (Details for study: CSD EPIC) now works at AstraZeneca, Horizon Place, 600 Capability Green, Luton, Bedfordshire LU1 3LU, UK – Email: betina.blak@astrazeneca.com

JOURNAL : Value in Health

REFERENCE: 13(3):A203

DOI : 10.1016/S1098-3015(10)72995-8

Impact of the UK public smoking ban on the prescribing of smoking cessation therapy in primary care – a THIN database study

More publications

Smoking and BMI in COPD and non-COPD patients

Cigarette smoking as a risk factor for schizophrenia or all non-affective psychoses

Does smoking cessation increase risk of knee replacement? A general population-based cohort study